BLACK WEEKSФлакони −15% · комплекти −10% · останалото −5%с кодБезплатна доставка в Германия от 200 €

Тази страница е преведена автоматично и може да съдържа грешки. Български ли е родният Ви език? Ще се радваме на Вашите отзиви и корекции.Изпратете отзив

The Peptide Desk The Peptide Desk
Dapagliflozin (Forxiga), снимка на продукта
Medication

Dapagliflozin (Forxiga)

Medication

  • Изпраща се от Германия

Поръчка

Единична цена - Безплатна доставка в Германия над 200 € по време на Black Weeks
  • DHL с проследяване
  • Дискретна опаковка

4.6 от 5 в Trustpilot73 отзива

Накратко

Dapagliflozin (Forxiga) в цифри

Ключовите стойности от нашия лексикон. Плъзнете точката по кривата, за да видите колко остава по изчисление след една доза.

Пълна статия в лексикона

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~12.9 hours

Half-life ~12.9 hours
After 26 hours: 25 %
Hour 1350 %Hour 24, next dose28 %Hour 2625 %Hour 3912.3 %Hour 653 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

about12.9hours

Class
SGLT2 inhibitorgliflozin, selective
Use
Oral1x daily
Sizes
10 mg1 size in the shop

Знания

Всичко за Dapagliflozin (Forxiga)

Подробна информация очаквайте скоро.

Дозиране

Зареждане на информацията за дозиране …

Повече в лексикона

FAQ

Често задавани въпроси

Източници за всеки отговор: статия в лексикона

Още въпроси?

Пишете ни, нашият екип ще Ви помогне.

How does dapagliflozin work?

It blocks the transporter SGLT2 in the kidney, which brings filtered sugar back into the blood. The sugar then leaves with the urine without insulin being needed. Breakdown runs mainly via the enzyme UGT1A9 to an inactive metabolite.

Does it help without diabetes?

In the trials on heart failure and chronic kidney disease the effect was similar with and without diabetes. With reduced pumping the risk of worsening or cardiac death fell by 26 percent.

What did the kidney trial show?

Among 4,304 participants 9.2 percent on dapagliflozin and 14.5 percent on placebo had an event (halved kidney function, kidney failure or death). 19 had to be treated to prevent one. The trial was therefore stopped early.

What is euglycaemic ketoacidosis?

Acidosis from ketones with nearly normal blood sugar. Because sugar does not rise much, it was recognised late in a case series. The authors advise checking ketones in case of nausea, vomiting or malaise. In the large diabetes trial it occurred in 0.3 versus 0.1 percent.

Does it lower heart attacks and strokes?

Not clearly in the diabetes trial with 17,160 patients: 8.8 versus 9.4 percent major cardiovascular events. Hospital stays for heart failure and kidney events did fall clearly.

Which side effects are known?

Serious genital infections or those leading to a stop occurred in 0.9 versus 0.1 percent, ketoacidosis in 0.3 versus 0.1 percent. In the heart failure trials volume depletion, kidney problems and low blood sugar were not more common than on placebo.

Свързани

Подобни продукти